Efficacy of imiquimod in solitary plaques of mycosis fungoides.

Abstract

Mycosis fungoides is the most common type of cutaneous T-cell lymphoma. The extent and type of skin involvement (T classification) and presence of lymph node or visceral involvement are important predictors in selecting the type of treatment. Skin directed treatment represents the most appropriate therapy for early stage disease. Current topical treatment including potent topical steroids and nitrogen mustard are associated with adverse effects such as cutaneous atrophy and contact dermatitis. In the present study, we tested the efficacy of imiquimod in mycosis fungoides plaques.

• Authors: N Onsun, H Ufacik, Y Kural, E Topçu, A Somay
• Journal: International journal of tissue reactions (Int J Tissue React) Vol. 27 Issue 4 Pg. 167-72 ( 2005) ISSN: 0250-0868 [Print] Switzerland
• PMID: 16440581 (Publication Type: Case Reports, Journal Article)

Chemical References

• Aminoquinolines
• Antineoplastic Agents
• Dermatologic Agents
• Imiquimod

Topics

• Aminoquinolines (pharmacology)
• Antineoplastic Agents (pharmacology)
• Dermatologic Agents (pharmacology)
• Female
• Humans
• Imiquimod
• Middle Aged
• Mycosis Fungoides (drug therapy, pathology, physiopathology)